China SXT Pharmaceuticals (SXTC) has had the highest return this year by a US stock in the Nasdaq Composite (IXIC), returning 825.4%.
| ASSET | YEAR | % RETURN |
|---|---|---|
China SXT Pharmaceuticals (SXTC) | 2025 | 825.4% |
Dominari (DOMH) | 2025 | 783.51% |
Magic Empire Global (MEGL) | 2025 | 228.06% |
Oncology Institute (TOI) | 2025 | 212.42% |
Jiuzi (JZXN) | 2025 | 207.14% |
Wang & Lee Group, Inc Ordinary Shares (WLGS) | 2025 | 206.9% |
Lottery, Inc Common Stock (LTRY) | 2025 | 205.51% |
Rapid Micro Biosystems (RPID) | 2025 | 197.8% |
Reborn Coffee (REBN) | 2025 | 183.04% |
Neuronetics (STIM) | 2025 | 180.61% |
VNET Group Inc DRC (VNET) | 2025 | 170.59% |
Invivyd (IVVD) | 2025 | 161.7% |
Avalon GloboCare (ALBT) | 2025 | 155.52% |
Yoshiharu Global (YOSH) | 2025 | 147.88% |
GRAIL, LLC (GRAL) | 2025 | 146.18% |
Noodles (NDLS) | 2025 | 143.54% |
Biomerica (BMRA) | 2025 | 135.52% |
Creative Medical Technology (CELZ) | 2025 | 116.45% |
Alpha Technology Group Limited Ordinary Shares (ATGL) | 2025 | 113.86% |
Cumberland Pharmaceuticals (CPIX) | 2025 | 112.7% |
Digital Turbine (APPS) | 2025 | 105.75% |
Coeptis Therapeutics (COEP) | 2025 | 102.88% |
Accolade (ACCD) | 2025 | 101.16% |
Lightbridge (LTBR) | 2025 | 99.6% |
Compass Therapeutics (CMPX) | 2025 | 98% |
